Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ceftibuten

An oral third-generation cephalosporin antibiotic. Approved in the United States in 1995, it is used for respiratory tract infections such as otitis media, pharyngitis, tonsillitis and flare-ups of chronic bronchitis; in other countries also for urinary infections. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?Thirty years on it is back in the spotlight: paired with ledaborbactam, a boron-based beta-lactamase inhibitor, it is being studied as an oral antibiotic against multidrug-resistant Enterobacterales, including carbapenemase producers.

CeftibutenGo to the active ingredient →
CeftibutenActive ingredientCeftibutenCat. No. P-C103-001CAS 97519-39-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.